Alembic Pharma stock slumps as US growth a concern
Alembic Pharma's lower-than-expected performance in Q1 and competition heating up in the US for some products have led to analysts cutting their forward earnings estimates28-07-2021
28-07-2021
Alembic Pharmaceuticals Ltd - 533573 - Shareholder Meeting / Postal Ballot-Outcome of AGM
With reference to the captioned matter, we would like to state that the 11th Annual General Meeting of the Company was held on 27th July, 2021 through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). Please find enclosed herewith: a) Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. b) Scrutinizers' Report on E-voting and Poll as per the provisions of Section 108 and 109 of the Companies Act, 2013 read with Companies (Management and Administration), Rules, 2014. We request you to kindly take the same on record.27-07-2021
Alembic Pharmaceuticals Ltd - 533573 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
With reference to the captioned matter, we would like to state that the 11th Annual General Meeting of the Company was held on 27th July, 2021 through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). Please find enclosed herewith: a) Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. b) Scrutinizers' Report on E-voting and Poll as per the provisions of Section 108 and 109 of the Companies Act, 2013 read with Companies (Management and Administration), Rules, 2014. We request you to kindly take the same on record.27-07-2021
Alembic Pharmaceuticals Ltd - 533573 - Proceedings Of The 11Th Annual General Meeting Held On 27Th July, 2021
In accordance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of the 11th Annual General Meeting of the Company held on 27th July, 2021. We request you to kindly take the same on record.27-07-2021
Alembic Pharma dips 8% on disappointing June quarter results
Ebitda (earnings before interest, taxes, depreciation, and amortization) margins declined 1258 basis points (bps) YoY to 17.8 per cent, due to higher other expenditure27-07-2021
Alembic Pharmaceuticals Ltd - 533573 - Unaudited Financial Results For The Quarter Ended 30Th June, 2021
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended 30th June, 2021. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021. b) Standalone Unaudited Financial Results for the quarter ended 30th June, 2021. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 1:30 p.m. and the time of conclusion was 2:50 p.m. We request you to kindly take the same on record.26-07-2021
Alembic Pharmaceuticals Ltd - 533573 - Outcome Of Board Meeting
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended 30th June, 2021. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021. b) Standalone Unaudited Financial Results for the quarter ended 30th June, 2021. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 1:30 p.m. and the time of conclusion was 2:50 p.m. We request you to kindly take the same on record.26-07-2021
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice for claiming shares from Company's Unclaimed Suspense Account published by the Company in English language newspaper on 20th July, 2021 in Business Standard. We request you to kindly take the same on record.20-07-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The exchange is hereby informed that the Company will hold Post Results Conference Call on 26th July, 2021 as per the enclosed details. We request you to kindly take the same on record.15-07-2021
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company has been reported as lost/misplaced and the registered shareholder(s) have requested the Company for issue of duplicate share certificate as per the attached letter. We enclose herewith an e-mail intimation received from Link Intime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record.15-07-2021